A new international study led by Tel Aviv University researchers may pave the way for an effective treatment for amyotrophic ...

New data suggest motor function improves with amifampridine. New phase 2 data for the spinal muscular atrophy (SMA) therapy amifampridine (Ruzurgi) suggests the drug is safe and effective at improving ...

Dedicated to advances in research and therapies on muscles and its diseases, the Myology 2022 Congress, organized by AFM-Téléthon, will bring together hundreds of scientists and international experts.

Motive Health, Inc., the innovative healthcare technology company behind the first FDA-cleared muscle stimulation device for ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, announced Dyno-bn8, a novel adeno-associated virus ...

Dyne Therapeutics, Inc. ( ($DYN) ) has released its Q3 earnings. Here is a breakdown of the information Dyne Therapeutics, Inc. presented to its ...

Edgar graduated from UCMT in 2010. In his decade-plus of experience as a massage therapist he has specialized in medical massage and neuromuscular therapy to help people recover from injuries and ...

June 7 (Reuters) - FibroGen Inc's (FGEN.O), opens new tab treatment for patients with a muscle-wasting disorder that typically binds them to a wheelchair failed to improve measures of upper limb ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new ...